These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15979063)

  • 21. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 22. Chromatographic separation of cholesteryl acetate and its chloro analogues.
    Bhat HK; Ansari GA
    J Chromatogr; 1989 Jan; 462():467-70. PubMed ID: 2738136
    [No Abstract]   [Full Text] [Related]  

  • 23. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
    Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
    BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of highly pure dolichyl and cholesteryl esters.
    Piretti MV; Pagliuca G
    Ital J Biochem; 1996 Jun; 45(2):67-9. PubMed ID: 8956904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic method for the sensitive and specific determination of hair lipids in combination with chromatography.
    Masukawa Y; Tsujimura H; Imokawa G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):131-42. PubMed ID: 16006202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
    Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
    Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.
    Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH; Chai CY
    APMIS; 2009 Mar; 117(3):176-84. PubMed ID: 19245590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomorphology of urothelial carcinomatous peritoneal effusion.
    Xiao GQ
    Cytopathology; 2008 Apr; 19(2):131-3. PubMed ID: 18241206
    [No Abstract]   [Full Text] [Related]  

  • 30. The molecular signature for urothelial carcinoma of the upper urinary tract.
    Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
    J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis in urothelial tumors of the upper urinary tract.
    Baderca F; Lighezan R; Dema A; Alexa A; Raica M
    Rom J Morphol Embryol; 2005; 46(4):263-8. PubMed ID: 16688360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization.
    Li CM; Chung BH; Presley JB; Malek G; Zhang X; Dashti N; Li L; Chen J; Bradley K; Kruth HS; Curcio CA
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2576-86. PubMed ID: 15980251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films.
    Norlén L; Gil IP; Simonsen A; Descouts P
    J Struct Biol; 2007 Jun; 158(3):386-400. PubMed ID: 17287132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
    Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
    Tsai YS; Tzai TS; Chow NH
    Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who is who among urothelial neoplasms?
    Klemm KM
    Adv Exp Med Biol; 2005; 563():21-9. PubMed ID: 16433119
    [No Abstract]   [Full Text] [Related]  

  • 39. Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.
    Barocas DA; Kawamoto H; Dreizin DF; Howard ME; Choi J; Pitts WR; You X; Tickoo SK; Boorjian SA; Scherr DS
    Urology; 2005 Nov; 66(5):1134-9. PubMed ID: 16286153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain.
    Yamashita R; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K
    Int J Urol; 2006 Nov; 13(11):1448-50. PubMed ID: 17083402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.